SPONSOR
ALX Oncology Inc.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: NSCLC (Advanced Non-small Cell Lung Cancer)HNSCCCRC (Colorectal Cancer)ESCCColo-rectal CancerHead and Neck CancerEsophageal Squamous Cell Carcinoma (ESCC)Breast Cancer, Metastatic
ALX Oncology Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC, CRC (Colorectal Cancer), ESCC.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — ALX Oncology Inc.
How many clinical trials has ALX Oncology Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by ALX Oncology Inc., of which 2 are actively recruiting participants. These trials cover conditions including NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC, CRC (Colorectal Cancer). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does ALX Oncology Inc. research focus on?
ALX Oncology Inc. clinical trials span NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC, CRC (Colorectal Cancer), ESCC, Colo-rectal Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a ALX Oncology Inc. clinical trial?
To participate in a ALX Oncology Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all ALX Oncology Inc. trials with current recruitment status updated daily.
Clinical Trials by ALX Oncology Inc.
NCT07085091 Phase 1
Recruiting
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
NSCLC (Advanced Non-small Cell Lung Cancer)
NCT07007559 Phase 2
Recruiting
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Breast Cancer, Metastatic
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology